Analysis
PublicCROSSJECT holds $11.3M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jun 21, 2027 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+
Recompete timing
PublicCurrent PoP ends Jun 21, 2027 (308 days remaining). Agencies typically plan 12–18 months ahead — at 10.1 months out, that window is already open. The buying decision is likely already in motion.
Watch this contract — one email →Incumbent footprint
Public recordCROSSJECT — $11.3M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open CROSSJECT’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50122C00031?
75A50122C00031 (ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGE…) is a Department of Health and Human Services (HHS) award with an estimated value of $104.2M, currently held by CROSSJECT. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50122C00031?
CROSSJECT is the incumbent with $11.3M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jun 21, 2027.
When does 75A50122C00031 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 21, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →